Regular use of acetaminophen (more than 2 grams daily for several days) can increase the anticoagulant effect of warfarin and raise the INR, increasing bleeding risk. While acetaminophen is generally recommended over NSAIDs for warfarin patients, high doses still require caution.
How This Interaction Works (Mechanism)
Acetaminophen's active metabolite, N-acetyl-p-benzoquinone imine (NAPQI), inhibits vitamin K-dependent carboxylase enzymes, which are needed to activate clotting factors. At higher doses, enough NAPQI accumulates to reduce the activity of clotting factors II, VII, IX, and X, potentiating warfarin's anticoagulant effect. The interaction typically becomes clinically significant at acetaminophen doses above 2 grams per day for more than 3 consecutive days.
Source: Journal of General Internal Medicine, Warfarin-Acetaminophen Interaction Study, 2024
Acetaminophen remains the preferred pain reliever for patients on warfarin, but limit use to less than 2 grams (2,000 mg) per day. If regular acetaminophen use is needed, check your INR after 3 to 5 days. Occasional single doses of acetaminophen are unlikely to cause problems. Avoid combination products that contain both acetaminophen and other active ingredients, as they may add to the risk.
Check More Drug Interactions
Use our free interaction checker to search thousands of drug, supplement, and food combinations.
Open Interaction CheckerEveryday safety with a blood thinner
As an Amazon Associate I earn from qualifying purchases.
Sources and standards behind this page
What a drug interaction does, and how strongly it is supported, is documented in public labeling and federal safety references rather than in any one summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- DailyMed carries the current FDA labeling for every marketed drug product, including the warnings and drug interaction sections.
- Drugs@FDA is the federal database of approved drug products and their approval documents.
- FDA: Drug interactions, what you should know explains how drug-drug, drug-food and drug-condition interactions are described on labels.
- FDA Drug Safety Communications publishes the agency's safety alerts and label changes as they are issued.
- FDA MedWatch is the program for reporting and reviewing adverse events, including suspected interactions.
- openFDA provides public access to FDA labeling and adverse event data.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medicine is and how it is taken.
- NIAAA: Harmful interactions documents which medicines interact with alcohol and how.
- NCCIH: Herb-drug interactions summarises the evidence on interactions between herbal products and medicines.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how this interaction works and where it is documented. It is not medical advice: a prescriber or pharmacist decides what applies to a particular patient and medication.
Frequently Asked Questions
Warfarin and Acetaminophen have a moderate interaction that requires caution. While some patients may take both under medical supervision, the combination can cause adverse effects. Talk to your doctor before combining these medications, and do not adjust doses on your own.
Regular use of acetaminophen (more than 2 grams daily for several days) can increase the anticoagulant effect of warfarin and raise the INR, increasing bleeding risk. While acetaminophen is generally recommended over NSAIDs for warfarin patients, high doses still require caution.
Yes. Anytime you are taking multiple medications, supplements, or substances, you should inform your doctor and pharmacist. They can evaluate your specific risk factors (age, kidney function, other medications, medical conditions) and determine whether the Warfarin and Acetaminophen combination is safe for you, or whether adjustments are needed.
Related Resources
Get Drug Safety Alerts
Leave your email for updates on FDA warnings, new drug interactions, and patient safety information. We have not started sending yet, and we will only email when we do.